Organigram Global (OGI) Change in Acquisitions & Divestments (2018 - 2026)
Organigram Global (OGI) posted quarterly Change in Acquisitions & Divestments of $591.4 million for Q1 2026, down 2.8% year-on-year from $608.4 million in Q1 2025, and up 99743.42% on a QoQ basis from $592313.3 in Q4 2025.
Organigram Global (OGI) Change in Acquisitions & Divestments (2018 - 2026) Analysis & Trends
Organigram Global (OGI) has reported Change in Acquisitions & Divestments for 7 consecutive years, with $591.4 million the latest figure, recorded in Q1 2026.
- Quarterly Change in Acquisitions & Divestments fell 2.8% year-over-year to $591.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 billion (down 88.57% YoY) and the FY2021 annual result came in at $60.0 million, changed N/A from the prior year.
- Change in Acquisitions & Divestments grew to $591.4 million in Q1 2026 per OGI's latest filing, from $592313.3 in the prior quarter.
- Over the last five years, Change in Acquisitions & Divestments for OGI reached as high as $608.4 million in Q1 2025 and fell as low as -$1.2 million in Q4 2024.
- A 3-year average of $299.8 million and a median of $296.0 million in 2026 frame the typical range for Change in Acquisitions & Divestments.
- Annual changes were most pronounced in 2025 — Change in Acquisitions & Divestments soared 149.88% — and 2026, when it slipped 2.8%.
- Year by year, Change in Acquisitions & Divestments stood at -$1.2 million in 2024, then surged by 149.88% to $592313.3 in 2025, then surged by 99743.42% to $591.4 million in 2026.
- According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $591.4 million, $592313.3, and $608.4 million for Q1 2026, Q4 2025, and Q1 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.91 Bn | 32.16 Bn | 1.97 Bn |
| 3 | Zoetis | 32.46 Bn | 30.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.13 Bn | 20.98 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.60 Bn | 12.18 Bn | 785.00 Mn |
| 10 | Organigram Global | 121.32 Mn | 154.39 Mn | 28.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 591.39 Mn |
| Mar 31, 2026 | 591.39 Mn |
| Dec 31, 2025 | 592,313.27 |
| Dec 31, 2025 | 592,313.27 |
| Mar 31, 2025 | 608.41 Mn |
| Mar 31, 2025 | 608.41 Mn |
| Dec 31, 2024 | -1.19 Mn |
| Dec 31, 2024 | -1.19 Mn |
| May 31, 2021 | -120.02 Mn |
| May 31, 2021 | -120.02 Mn |
| Feb 28, 2021 | 10.00 Bn |
| Feb 28, 2021 | 10.00 Bn |
| Nov 30, 2020 | 30.00 Bn |
| Nov 30, 2020 | 30.00 Bn |
| May 31, 2020 | 97.25 |
| May 31, 2020 | 97.25 |
| Feb 29, 2020 | 103,000.00 |
| Feb 29, 2020 | 103,000.00 |
| Aug 31, 2019 | 380.00 |
| Aug 31, 2019 | 380.00 |